American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

May 20, 2021

Newsletter Sponsor

Catalent’s New OneXpress Solution

Overseen by a dedicated program manager from start to finish, Catalen’ts NEW OneXpress Solution combines phase-appropriate technologies and proven expertise, with scalable end-to-end capabilities throughout an extensive supply network, to achieve optimal accelerated manufacturing solutions at every stage.

	Industry News

Sandoz Announces Plans to Further Strengthen its Antibiotics Manufacturing Setup in Europe
Sandoz has announced plans to further strengthen its European antibiotics manufacturing network by ... read more »

BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business
BD will build a €165 million ($200 million USD) high-tech manufacturing facility in city of Zaragoza... read more »

Maxwell Biosciences Develops a New Viral Treatment Therapeutics Platform
Maxwell Biosciences, a biotechnology company, announced patented biostable peptide analogs that ... read more »

	Infographic

Looking Beyond Phase 1 Trials: Situations and Consequences
In the rush to get a promising treatment into Phase 1 trials quickly and inexpensively, many companies choose a service provider that only has ... read more »

	Featured Articles

Microbial Considerations for the Selection of Aseptic Connectors The application of single-use, sterile and disposable technology is encouraged by regulators, as the draft to EU GMP Annex 1 indicates. Such ... read more »

Base Editing: A New Player in the Cell and Gene Therapy Space Last December, Vertex Pharmaceuticals and CRISPR Therapeutics shared initial clinical trial data from studies on CTX001, a cell-based therapy for ... read more »

	Featured Video

On-Demand Webinar: The Modern Microbiologist’s No-Nonsense Guide to Quality Control
In this webinar, you’ll learn the essentials of Growth Promotion Testing, why Environmental Monitoring should be a part of your QC program, and a year... watch »

On-Demand Webinar: Building Cleanrooms At Warp Speed
In this webinar, you’ll learn about the additional challenges COVID presented to already compressed timelines and the strategies AES utilized to ... watch »

	Featured Whitepaper

White paper: Advantages of Antibody-based Selectivity in the Purification of Next Generation Biologics
It has been almost 40 years since the first biologic drug reached the market. That drug was human insulin, which was produced by cloning human genes into E. coli for protein expression at a scale ... read more »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA